Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

Company Overview - Apyx Medical Corporation is an advanced energy technology company focused on innovative products, including its Helium Plasma Platform Technology marketed as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market [2] - The effectiveness of Renuvion and J-Plasma is supported by over 90 clinical documents, showcasing the company's commitment to clinical validation [2] Financial Results Announcement - Apyx Medical will release its financial results for the third quarter of fiscal year 2024 before the market opens on November 8, 2024 [1] - Management will host a conference call at 8:00 a.m. Eastern Time on the same day to discuss the quarterly results and conduct a question-and-answer session [1] - Interested parties can access the call by phone or through a live webcast, which will also be archived for future reference [1]